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Purpose: To investigate the performance of T1 and T2 mapping to detect intramyocardial hemorrhage (IMH) in ST-
segment elevation myocardial infarction (STEMI) patients treated by primary percutaneous coronary intervention
(PPCI).
Materials and Methods: Fifty STEMI patients were prospectively recruited between August 2013 and July 2014 following
informed consent. Forty-eight patients completed a 1.5T cardiac magnetic resonance imaging (MRI) with native T1, T2,
and T2 maps at 462 days. Receiver operating characteristic (ROC) analyses were performed to assess the performance
of T1 and T2 to detect IMH.
Results: The mean age was 596 13 years old and 88% (24/48) were male. In all, 39 patients had interpretable T2 maps
and 26/39 (67%) of the patients had IMH (T2 <20 msec on T

2 maps). Both T1 and T2 values of the hypointense core
within the area-at-risk (AAR) performed equally well to detect IMH (T1 maps AUC 0.86 [95% confidence interval [CI]
0.72–0.99] versus T2 maps AUC 0.86 [95% CI 0.74–0.99]; P5 0.94). Using the binary assessment of presence or absence
of a hypointense core on the maps, the diagnostic performance of T1 and T2 remained equally good (T1 AUC 0.87 [95%
CI 0.73–1.00] versus T2 AUC 0.85 [95% CI 0.71–0.99]; P50.90) with good sensitivity and specificity (T1: 88% and 85%
and T2: 85% and 85%, respectively).
Conclusion: The presence of a hypointense core on the T1 and T2 maps can detect IMH equally well and with good sen-
sitivity and specificity in reperfused STEMI patients and could be used as an alternative when T2 images are not
acquired or are not interpretable.
Level of Evidence: 2
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Primary percutaneous coronary intervention (PPCI) is thereperfusion strategy of choice in ST-segment elevation
myocardial infarction (STEMI). However, paradoxically, the
process of reperfusion itself can lead to microvascular obstruc-
tion (MVO) and intramyocardial hemorrhage (IMH).1,2 Nearly
50% of patients develop MVO,3 and 35–40% have IMH,4,5 as
detected by cardiac magnetic resonance (MR). Both MVO and
IMH are associated with larger myocardial infarct (MI) sizes,
adverse left ventricular (LV) remodeling and poor clinical out-
comes, as recently summarized in two meta-analyses.3,4 Cardiac
MR within the first week following STEMI using T 2 imaging
has been shown to detect IMH in animal models of acute
MI6,7 and a threshold value of T* <20 msec has subsequently
been used in several clinical studies as the reference for
IMH.2,5,8,9 Although T 2 imaging is currently the reference
standard for the detection of IMH, it is prone to motion, flow
and off-resonance artifacts.10 In a recent study by Carrick
et al,5 only 86% of patients had analyzable T 2 data. Further-
more they also showed that MVO and IMH are dynamic and
follow distinct time courses and had different prognostic
significance.5
T2-weighted short tau inversion recovery (STIR) imaging,
which has been used to delineate the area-at-risk (AAR) in
reperfused STEMI patients, has also been used to detect IMH
as the presence of a hypointense core within the AAR.11–13
However, STIR imaging has been shown to have a lower diag-
nostic performance for detecting IMH when compared to T 2
imaging.7,8 Native T1 and T2 maps have been explored as alter-
native methods for quantifying the AAR in reperfused STEMI
patients14,15 and MVO and IMH can also manifest as a hypo-
intense core on the native T1
9,16 and T2 maps.
7,17,18 However,
the diagnostic performance of native T1 and T2 maps to detect
the presence of IMH and MVO following STEMI has not
been directly compared. Therefore, the main aim of this study
was to investigate the performance of hypointense core on the
native T1 (referred to as T1 throughout the article for simplici-
ty) and T2 maps to detect IMH within the first week in reper-
fused STEMI patients, using T 2 mapping as the reference
standard for IMH.2,5–9 Secondly, we also aimed to assess the
performance of the hypointense core on the T1 and T2 maps
to detect early and late MVO, using gadolinium enhancement
as the reference standard for MVO.12,19–22
Materials and Methods
Study Population
The local Ethics Committee approved this study. The patients includ-
ed in this study have been previously reported.23–25 In brief, between
August 2013 and July 2014, consecutive patients were screened and
50 STEMI patients reperfused by PPCI within 12 hours of onset
(diagnosis and treatment as per current guidelines26,27 were prospec-
tively recruited at one center. The main exclusion criteria were previ-
ous MI and standard recognized contraindications to cardiac MR
such as estimated glomerular filtration rate <30mL/min, ferromag-
netic implants, and known claustrophobia.
Cardiac MR Acquisition
Cardiac MR was performed on a 1.5T scanner (Magnetom Avanto,
Siemens Medical Solutions, Erlangen, Germany) using a 32-
channel phased-array cardiac coil. The imaging protocol included
full left ventricular (LV) short axis coverage of cines, native T1
mapping, T2 mapping, three (basal, mid, and apical) LV short axis
slices of T 2 mapping and full LV short axis coverage of early and
late gadolinium enhancement (EGE and LGE). All the short axis
images were aligned with the cine short axis slice position. Colored
T1/T/T

2 maps using the default look up table from the scanner
were generated.
NATIVE T1 MAPPING (WORK IN PROGRESS 448B, SIEMENS
HEALTHCARE). Native T1 maps were acquired with a steady-
state free precession (SSFP)-based modified Look–Locker inversion
recovery (MOLLI) sequence (flip angle5 358; pixel bandwidth
977Hz/pixel; matrix5 256 3 144; echo time5 1.1 msec; slice
thickness 6mm; uninterpolated resolution5 1.5 3 1.5mm) using
a 5s(3s)3s sampling protocol.28 Motion correction and a nonlinear
least-square curve fitting of the set of images acquired at different
inversion times were performed inline by the scanner to generate a
pixel-wise colored T1 map.
29
T2 MAPPING (WORK IN PROGRESS 448B, SIEMENS HEALTH-
CARE). Colored T2 maps consisting of pixel-wise T2 values were
generated inline following motion correction and fitting to estimate
T2 relaxation times
30 after acquiring three single-shot images (flip
angle5 708; pixel bandwidth 930Hz/pixel; matrix5 116 3 192;
echo time5 1.1 msec; repetition time5 3 3 R-R interval; slice
thickness5 6mm; uninterpolated resolution5 2.0 3 2.0mm) at
different T2 preparation times (0 msec, 24 msec, and 55 msec,
respectively).
T2 MAPPING (WORK IN PROGRESS 448B, SIEMENS HEALTH-
CARE). T 2 maps were obtained (bandwidth 814(38) Hz/pixel;
echo times 3 8: 2.7, 5, 7.3, 9.6, 11.9, 14.2, 16.5, 18.8 msec; flip
angle5 188; matrix5 256 3 115; slice thickness5 8mm; uninter-
polated resolution5 1.6 3 1.6mm) and a colored pixel-wise T 2
map was generated inline by the scanner.
EARLY AND LATE GADOLINIUM ENHANCEMENT. EGE
images were acquired 1–2 minutes after the injection of 0.1 mmol/
kg of gadoterate meglumine (Gd-DOTA marketed as Dotarem,
Guerbet, Paris, France) using inversion recovery single-shot SSFP
T1-weighted sequence at a fixed high inversion time of 440 msec
19
(typical imaging parameters: bandwidth 898Hz/pixel; echo time-
5 1.1 msec; repetition time5 700–900 msec; flip angle5 508;
acquisition matrix5 110 3 192; slice thickness5 8mm; uninter-
polated resolution5 2.1 3 2.1mm). LGE images were acquired
after 10–15 minutes, using either a standard segmented “fast low-
angle shot” 2D inversion-recovery gradient echo sequence LGE
phase sensitive inversion recovery (PSIR) sequence (in 25/48
patients; typical imaging parameters: bandwidth 140Hz/pixel; echo
time5 3.2 msec; repetition time5 700–900 msec; flip angle5 218;
acquisition matrix5 125 3 256; slice thickness5 8mm; uninterpo-
lated resolution5 1.6 3 1.6mm) or a respiratory motion-corrected,
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free-breathing single-shot SSFP averaged PSIR sequence31 (in 23/48
patients; typical imaging parameters: bandwidth 977Hz/pixel; echo
time5 1.48 msec; repetition time5 700–900 msec; flip angle5 508;
acquisition matrix5 144 3 256; slice thickness5 8mm: uninterpo-
lated resolution5 1.6 3 1.6mm).
Cardiac MRI Analysis
Imaging analysis was performed using CVI42 software (v.
5.1.2[303], Calgary, Canada). The endocardial and epicardial bor-
ders were manually drawn and MI size was quantified in grams
and as a percentage of the LV volume (%LV) using a signal inten-
sity threshold of 5 standard deviations (SD)32 above the remote
myocardium. Areas of hypointense core of MVO were manually
included as part of the MI zone.
Although the T1 and T2 maps were performed with breath-
hold and motion-correction, the raw images were visually assessed
for any misalignment due to significant motion between single-
shot raw images, mistriggering, partial volume effects, and artifacts
as previously described by von Knobelsdorff-Brenkenhoff et al.33
The T 2 maps and their raw images were visually assessed for
breathing, motion, and off-resonance artifacts.
The endocardial and epicardial borders were manually drawn
on the T2 maps and the AAR was obtained using a threshold of
2SD34,35 above the remote myocardial T2 relaxation time and
expressed as %LV. Areas of hypointense core within the areas of
hyperenhancement were manually included as part of the MI zone.
On the T1 and T2 maps matching the T

2 maps, the 2SD
threshold was also used to identify the hypointense core (hypoin-
tense area within the hyperenhanced area with a subendocardial mar-
gin) on both maps to identify the AAR and the hypointense core
(Fig. 1). So far, no studies have validated a cutoff threshold to detect
IMH and MVO from these maps and we chose to use the same
threshold used to quantify the AAR to delineate the hypointense
core as a semiautomated method to minimize bias (Fig. 1). These
areas were included as part of the MI zone and AAR. Regions of
interest (ROIs) were manually drawn in the hypointense core
(expressed as T1Core and T2Core), the salvaged myocardium within
the AAR (expressed as T1Salvage and T2Salvage), and the remote myo-
cardium (expressed as T1Remote and T2Remote) on both maps. In cases
when no hypointense core was identified, the ROI was drawn in the
area of infarct. The T1 and T2 maps were also graded in a binary
fashion to detect the presence or absence of a hypointense core
(with the help of the semiautomated method as above).
Ten randomly selected patients were separately analyzed by
two investigators, 2 months apart for intraobserver and interobserv-
er variability.
Corresponding ROIs were drawn in the hypointense core of
the T 2 maps and the remote myocardium (colocalized with the ROIs
on the T1 and T2 maps) and representative values were recorded.
CARDIAC MR DEFINITIONS. IMH was defined as a hypointense
core on the T 2 maps with a T

2 <20 msec as previously validated
6
and subsequently used in several clinical STEMI studies.2,5,8,9
FIGURE 1: Semiautomated method used to identify the hypointense core on the T1 and T2 maps.
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Early MVO was defined as areas of dark core within the
infarcted territory visually detected (red arrow on the EGE image
in Fig. 2) on the EGE images as previously described.12,19,20
Late MVO was defined as areas of dark core within the areas of
LGE (red arrow on the LGE image in Fig. 2) acquired 10–15 minutes
postcontrast on the LGE images as previously described.12,21,22
The above definitions were used for the reference standard
by cardiac MR for IMH, early MVO, and late MVO.
Statistical Analysis
Statistical analysis was performed using SPSS v. 22 (IBM, Armonk,
NY) and MedCalc for Windows v. 15.6.1 (Medcalc Software, Ost-
end, Belgium). Continuous data were expressed as mean6 SD or
median (interquartile range) and compared using paired or
unpaired tests where appropriate. Categorical data were reported as
frequencies and percentages. Patients with no interpretable T 2
maps were excluded from the analysis. Receiver operating charac-
teristic (ROC) analyses were used to assess the diagnostic perfor-
mance for T1 and T2 maps for detecting IMH on the acute scans
and were compared using the method described by Delong et al.36
Interobserver and intraobserver variability for T1 and T2 values of
the hypointense core were assessed in 10 patients and expressed as
an intraclass correlation coefficient (ICC) (95% confidence interval
[CI]). Cohen’s kappa was used to assess interobserver and intraob-
server agreement for the binary assessment of the maps. All statisti-
cal tests were two-tailed, and P < 0.05 was considered statistically
significant.
Results
Figure 3 provides the details of the patients’ screening and
recruitment into the study. Forty-eight patients with a mean
age of 596 13 years and 88% (42/48) male gender com-
pleted the cardiac MR study at 46 2 days post-PPCI.
Patients’ clinical characteristics are listed in Table 1. The
median onset-to-balloon time was 182 (128–328) minutes.
The mean MI size was 27.46 14.6% of the LV and the
AAR was 42.76 11.9% of the LV. Early MVO was present
in 79% (38/48) of patients and late in 63% (30/48) of
patients.
Ten percent of the T1 and T2 maps were not interpret-
able and were predominantly the basal or apical slices. All
FIGURE 2: Example of a patient with an acute inferior MI depicting the evidence of MVO on EGE and LGE scans with corresponding
hypointense cores (red and black arrows) on the basal LV short axis T 2, T1, and T2 maps.
FIGURE 3: Details of the screening and recruitment of patients entering this study.
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patients had a least one short axis T1 and T2 map matching
the T 2 maps. T

2 maps were not interpretable in 19% (9/
48) of the patients (due to motion flow and off-resonance
artifacts) but their corresponding T1 and T2 maps were
interpretable.
The average scanning time was 596 4 minutes, longer
than a clinical cardiac MR scan, as on average an additional
15 minutes was required for T1 and T2 mapping acquisition
(full LV coverage) and an additional 3 minutes for three
short-axis T 2 mapping acquisitions.
Figure 2 shows an example of the different imaging
modalities acquired. These are mid-LV short axis images of
a patient with an acute inferior STEMI with MVO and the
corresponding maps showing IMH (arrows).
A hypointense core was present on the T2 maps in
60% (29/48) of the patients and on the T1 maps in 63%
(30/48) of the patients. Sixty-seven percent (26/39) of the
patients with interpretable T 2 maps had IMH.
T 2 Mapping for the Detection of IMH (n539)
In patients with a hypointense core on the T 2 maps, the
mean T 2 value of the core was 136 3 msec compared to
336 4 msec in the remote myocardium, P < 0.001. IMH
occurred in 67%(26/39) of patients. As expected, patients
with IMH were more likely to have larger MI size
(33.46 11.3% of the LV vs. 17.56 9.8% of the LV, P <
0.001) and worse ejection fraction (476 7% vs. 536 7%,
P5 0.04). Further details on the cardiac MR findings are
summarized in Table 2.
Detection of IMH by T1 and T2 mapping (n539)
In patients with IMH, T1Core was lower than T1Remote
(9976 79 msec vs. 10356 46 msec, P5 0.02) whereas
T2Core was similar to T2Remote (506 4 msec vs. 516 3
msec, P5 1.0). In patients without IMH, T1Core and T2Core
were higher than T1Remote and T2Remote as shown in Fig. 4.
ROC analyses of the T1 and T2 values of the hypointense
core showed that both mapping techniques performed
equally well at detecting IMH on the acute scans (T1 maps:
area under the curve (AUC) 0.86 [95% CI 0.72-0.99], cut-
off value for T1Core: <1080 msec; T2 maps: AUC 0.86
[95% CI 0.74-0.99]; P5 0.94, cutoff value for T2Core: <54
msec) (Fig. 5). When using the binary assessment of either
presence or absence of a hypointense core on the T1 and T2
maps as a measure to detect IMH, T1 and T2 performed as
well as the quantitative assessment of the maps (T1: AUC
0.87 [95% CI 0.73-1.00], T2: AUC 0.85 [95% CI 0.71-
0.99]; P5 0.90). The presence of a hypointense core had a
sensitivity of 88% and a specificity of 85% to detect IMH
on the T1 maps and a sensitivity of 85% and specificity of
85% on the T2 maps. The accuracy by T1 mapping was
87% and 85% by T2 mapping. The positive predictive value
by T1 and T2 mapping were both 92%. The negative pre-
dictive value was highest by T1 mapping at 87% and 85%
by T2 mapping.
Detection of Early and Late MVO by T1 and T2
Maps (n548)
The AUC for the presence of a hypointense core on the maps
to detect early MVO was 0.83 (95% CI 0.70–0.97) for T1
(sensitivity: 76%; specificity: 90%) and 0.82 (95% CI 0.69–
0.97) for T2 (sensitivity: 77%; specificity: 90%). For the detec-
tion of late MVO the AUC was 0.79 (95% CI 0.64–0.95) for
T1 (sensitivity: 84%; specificity: 71%) 0.80 (95% CI 0.62–
0.93) for T2 (sensitivity: 80%; specificity of 72%).
Table 3 summarizes further details on the diagnostic
performances of T1 and T2 maps to detect IMH, early
MVO, and late MVO.
ROC Comparison for the Detection of IMH, early
MVO, and Late MVO
There was no significant difference in the diagnostic perfor-
mance for T1 and T2 mapping to detect IMH, early MVO,
TABLE 1. Clinical Characteristics of STEMI Patients
Details Number
Number of patients 48
Male 40 (83%)
Age 586 13
Diabetes mellitus 9 (19%)
Hypertension 15 (31%)
Smoking 15 (31%)
Dyslipidemia 15 (31%)
Chest pain onset to PPCI time (min) 182 (128-328)
Infarct artery (%)
LAD 28 (58%)
RCA 18 (38%)
Cx 2 (4%)
Pre-PPCI TIMI flow (%)
0 38(80%)
1 1 (2%)
2 4 (8%)
3 5 (10%)
Post-PPCI TIMI flow (%)
0 1 (2%)
1 0 (0%)
2 10 (21%)
3 37 (77%)
LAD: left anterior descending artery; RCA: right coronary
artery; Cx: circumflex artery; TIMI: thrombolysis in myocardial
infarction.
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TABLE 2. Cardiac MR Characteristics of STEMI Patients Divided Into Those With and Without IMH
With IMH (n5 26) Without IMH (n5 13) P value
EDV/ml 1726 44 1526 17 0.06
ESV/ml 916 30 736 16 0.02a
EF/% 476 7 536 7 0.04a
LV Mass/g 1176 44 1116 23 0.66
Infarct size/ % of LV 33.46 11.3 17.56 9.8 <0.001a
Infarct size/ g 24.96 8.6 11.46 8.0 <0.001a
AAR/ %LV 46.56 10.8 37.56 13.3 0.03a
Late MVO/ % (n) 96 (25) 8 (1) <0.001a
Early MVO/ % (n) 100 (26) 46 (6) 0.02a
T1Core/ ms 9976 79 11246 65
b <0.001a
T1Remote/ ms 10356 46 10146 55
b 0.03a
T1Salvage/ ms 12446 79 12676 65 0.43
T2Core/ ms 506 4 576 4 <0.001
a
T2Remote/ ms 516 3 506 3 0.35
T2Salvage/ ms 666 6 666 7 0.85
aDenotes statistically significant.
bIncludes patients with and without a detectable hypointense core.
IMH: intramyocardial hemorrhage; EDV: end diastolic volume; ESV: end systolic volume; EF: ejection fraction; LV: left ventricular
mass; AAR: area-at-risk; MVO: microvascular obstruction.
FIGURE 4: T1 and T2 values of the hypointense core, remote myocardium, and the salvaged myocardium. *Statistically significant
difference.
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and late MVO (P values for ROC curves comparison for
IMH vs. early MVO, IMH vs. late MVO, early MVO vs.
late MVO for T1 mapping: 0.90, 0.43, 0.37, respectively;
for T2 mapping: 0.81, 0.58, and 0.42 respectively)
Early MVO With and Without IMH (n532)
Thirty-two patients had analyzable T 2 maps and early
MVO. Eighty-one percent (26/32) of the patients had early
MVO with IMH and 19% (6/32) of the patients had early
MVO without IMH. Both T1 and T2 values were signifi-
cantly lower in patients with early MVO with IMH com-
pared to those with early MVO without IMH (T1Core:
998[954–1036] msec vs. 1116[1085–1168], P < 0001;
T2Core: 50[48–53] msec vs. 55[54–56] msec, P5 0.005).
The same comparison was not performed for late MVO as
only one patient had late MVO without IMH. All patients
with early MVO with IMH developed late MVO compared
to 2/6 (33%) of those with early MVO without IMH had
late MVO, P < 0.0001.
Interobserver and Intraobserver Variability (n510)
On the quantitative mapping analysis of the hypointense
core, for intraobserver variability the ICC for the quantifica-
tion of the hypointense core for the T1 maps was 0.944
(0.792–0.986) and for T2 maps was 0.903 (0.637–0.976).
For interobserver variability, the ICC for T1 maps was
0.935 (0.746–0.984) and for T2 maps was 0.887 (0.528–
0.972). On the qualitative mapping analysis for the hypoin-
tense core detection using the semiautomatic method, the
interobserver and intraobserver agreement was 100%, Cohen’s
kappa5 1.0, P < 0.0001.
Discussion
We have shown that the presence of a hypointense core
within the area if hyperenhancement (AAR) on the T1 and
T2 maps obtained at day 4 following a reperfused STEMI
detected the presence of IMH with good specificity and sen-
sitivity compared to the reference standard method using
T 2 maps. The binary assessment of presence or absence of a
hypointense core performed as well as the quantitative
assessment of the actual T1 and T2 values of the hypoin-
tense core. However, T 2 maps are still the modality of
choice when available, as the accuracy for T1 and T2 maps
to detect IMH was only 85 to 87%, respectively. T1 and T2
maps provide an alternative option for the detection of
IMH when T 2 imaging is not available.
The presence of a hypointense core on the T1 and T2
mapping performed equally well to detect early and late
FIGURE 5: ROC curves for the diagnostic performance of T1 and
T2 mapping to detect IMH on the acute scans when compared
to T2 maps
TABLE 3. Summary of the Diagnostic Performances of T1 and T2 Maps to Detect IMH, Early MVO, and Late
MVO
Sensitivity/ % Specificity/ % Positive predictive
value/ %
Negative predictive
value/ %
Accuracy/ %
IMH
T1 map 88 85 92 79 87
T2 map 85 85 92 73 85
Early MVO
T1 map 76 90 97 50 79
T2 map 74 90 97 47 77
Late MVO
T1 map 84 71 87 72 81
T2 map 80 72 86 68 79
IMH: intramyocardial hemorrhage; MVO: microvascular obstruction.
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MVO. This is not surprising for late MVO, as most
patients with late MVO also had IMH and therefore this
approach performs well to detect hemorrhagic MVO in our
cohort. Although numerically the AUCs were higher for the
detection of early MVO than late MVO, ROC curves com-
parison did not show a statistical difference. T1 and T2
mapping could differentiate between early MVO with and
without IMH. Furthermore, those with IMH were more
likely to display late MVO. Early MVO likely represents a
spectrum of etiologies for microvascular injury and late
MVO represents the more severe form as IMH. A recent
study37 using a porcine model of MI showed that T2-STIR
imaging could not discriminate between IMH and MVO
but imaging was performed at 8 days and no T 2 data were
acquired. Given the recent evidence of the dynamic nature
for the detection of the paramagnetic properties of IMH,38
it is not possible to put the results of that study into context
with our findings.
T1 of the infarct core was recently shown to be more
prognostic than LV ejection fraction, infarct core T2, and
IMH in a large cohort of STEMI patients.9 In a separate
article of the same cohort of patients, Carrick et al5 showed
that IMH was more closely associated with adverse LV
remodeling than late MVO, but their timing of cardiac MR
was a mean of 2.1 days and 87% of their patients with
MVO had IMH. They also demonstrated the dynamic
nature of MVO and IMH peaked at 2.9 days.5 So far, in
other studies using T 2 for detection of IMH, CMR were
performed at 2–3 days (O’Regan et al2: Day 3; Mather
et al19: Day 2; Kali et al7: Day 3: Kandler et al8: Day 3;
Zia et al17: Day 2). Whether performing cardiac MR 3
days post-PPCI (our study: mean of 4 days—96% with
MVO had IMH) may reveal more patients with MVO and
IMH, which would have more prognostic significance,
remains to be tested in future adequately powered studies.
The hypointense core on the T2 maps in reperfused
STEMI patients has been noted in previous studies and was
thought to be due to IMH.17,35 Pedersen et al39 previously
showed that T1-weighted inversion recovery images could
detect IMH with high sensitivity and specificity in a porcine
model of acute STEMI. However, we are the first study to
directly compare the diagnostic performance of T1 and T2
mapping to detect IMH against T 2 mapping in the clinical
setting.
The mechanism of the low signal within the areas of
IMH has previously been attributed to the paramagnetic
properties of hemoglobin breakdown products.20 However,
degradation of the extravasated erythrocytes to oxyhemoglo-
bin, deoxyhemoglobin, and methemoglobin (strongly para-
magnetic) is dynamic and would exhibit different T1 and
T2 properties at various stages as previously described by
Bradley et al40 in brain imaging. T2 was better at identifying
deoxyhemoglobin, whereas T1 was better at detecting
methemoglobin40 and this may explain the difference in
sensitivities for T1 and T2 maps to detect IMH in our study.
Breakdown of the erythrocyte membrane eventually leads to
ferritin and hemosiderin deposits within macrophages.20
Although T 2 is the most sensitive to detect IMH, it is
prone to motion artifacts due to relatively long breath-hold
duration and this has led to the development of free-
breathing T 2 mapping using motion corrected averaging.
10
However, this is not widely available yet and therefore T1
and T2 mapping, which is increasingly becoming available
in most centers performing STEMI research, may be an
alternative option to assess for IMH and MVO. This approach
would minimize patients dropping out of studies when T 2
mapping was not acquired or were not interpretable.
The mechanism for a hypointense core on the T1 and
T2 maps in patients without IMH but with MVO is not
clear. It has been postulated that this may be due to a local-
ized reduction in tissue water content due to obstruction of
the capillaries by distal embolization and plaques and cellu-
lar debris and compression from extrinsic edema.5,35 The
alternative explanation could be that the hypointense core
on the T1 and T2 maps may still represent IMH but the
hemoglobin degradation products are not paramagnetic
enough to be detected by T 2 if imaged too early; more
work remains to be done.
Limitations
This was a small study of 39 patients and no formal power
calculation was performed, but was similar in size to previ-
ous studies7,19,41,42 and the large prevalence of IMH in our
cohort may have been due to chance. Using a more conser-
vative prevalence for IMH of 40% (expected AUC 0.85),
the sample size required in prospective studies would need
to be 85 patients (PASS 14 Power Analysis and Sample Size
Software; 2015; NCSS, Kaysville, Utah) and almost double
the number if the performance of the hypointense core on
the T1 and T2 maps were assessed to differentiate between
MVO with and without IMH. A large number of the T 2
maps were not interpretable in our study predominantly
due to motion, flow, and off-resonance artifacts and this
highlights the challenge of performing a comprehensive car-
diac MR scan with multiparametric mapping in acutely
unwell STEMI patients (average scanning time of 1 hour)
and also shown in a recent large study with 14% of T 2
maps being not analyzable.5 We did not quantify the extent
of IMH, as whole coverage for T 2 were not available and
this was not the aim of this study, and some patients with
small areas of IMH may have been missed. Histological vali-
dation for the low T1 and T2 of the hypointense core was
not possible in this study and warrants further investigation.
We used two LGE readouts to accommodate for patients
who preferred not to breath-hold for the LGE acquisition
given the long duration of the scan, and the difference in
Journal of Magnetic Resonance Imaging
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signal-to-noise ratio between the two may have affected the
detection of MVO. The large majority of our patients with
MVO also had IMH. Therefore, we could not assess wheth-
er the hypointense core on the T1 and T2 maps could dif-
ferentiate between late MVO with IMH and late MVO
without IMH. However, we did find a difference in the
T1Core and T2Core between those with early MVO with
IMH and early MVO without IMH and this needs to be
confirmed in future studies. We did not acquire data on
black blood T2-STIR images or susceptibility-weighted car-
diac MRI (which has been shown to improve the detection
of IMH at 1.5 T43 and 3T41 for comparison. The reduction
in T1 and T2 using SSFP readouts could have been due to a
combination of both the on-resonance and off-resonance
signals from the paramagnetic components of the IMH and
this was not elucidated in this study.
In conclusion, the presence of a hypointense core on
T1 and T2 maps within the first week following a STEMI
can detect IMH equally well and with good sensitivity and
specificity. The T1 and T2 mapping techniques provide an
alternative approach for the detection of IMH in situations
when T 2 maps are not interpretable or not available. How-
ever, T 2 mapping currently remains the reference standard
in the clinical setting and T1 and T2 mapping therefore
may play a complementary role in future studies targeting
IMH.
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